Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 80-88, January 1, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schröter, C.
Right arrow Articles by Schulte-Hermann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schröter, C.
Right arrow Articles by Schulte-Hermann, R.

Dose-Response Studies on the Effects of {alpha}-, ß-, and {gamma}-Hexachlorocyclohexane on Putative Preneoplastic Foci, Monooxygenases, and Growth in Rat Liver1

C. Schröter, W. Parzefall2, H. Schröter and R. Schulte-Hermann2,3

Institut für Toxikologie und Pharmakologie der Universität Marburg, Pilgrimstein 2, D-3550 Marburg, Federal Republic of Germany

{alpha}-, ß-, and {gamma}-hexachlorocyclohexane ({alpha}-, ß-, {gamma}-HCH) isomers are widespread environmental pollutants; {alpha}-HCH can cause liver tumors in rats and mice. In the present study we have checked first the tumor-initiating activity of HCH using the appearance of phenotypically altered foci in female rat liver as an end point. Foci were identified by means of the {gamma}-glutamyltransferase (GGT) reaction and by morphological alterations. No evidence of initiating activity was found. Secondly, we have attempted to determine quantitatively the ability of HCH isomers to promote tumor development. For this purpose growth and phenotypic changes of foci were used as an end point. Rats received a single dose of N-nitrosomorpholine. Then five different doses of each HCH isomer or phenobarbital (PB) (as a positive control) were administered continuously via the diet for 4, 15, and 20 weeks. Both number and size of altered foci were enhanced by doses of 2 to 3 mg/kg or more of the three isomers; in addition, foci phenotypes showed a pronounced shift towards strong expression of GGT and sharp demarcation from the surrounding liver. Based on daily doses the three HCH isomers were approximately equipotent; based on concentrations in liver or adipose tissue, {gamma}-HCH was severalfold more effective than {alpha}- and ß-HCH. Thirdly, size and DNA and monooxygenase activities of the liver were determined. All three parameters were enhanced by HCH isomers and PB. However, no strict correlations were found. Rather, at the highest doses tested PB was the most effective inducer of monooxygenases, {alpha}-HCH was the most potent inducer of liver growth, and all three HCHs were more potent than PB as inducers of focal expansion. Thus, induction of liver growth appears to be associated with foci expansion (tumor promotion); however, neither liver growth nor monooxygenase induction can be used for quantitative predictions of foci expansion by chemical compounds. Finally, no-observed-effect levels were estimated for the parameters studied and are discussed in relation to human exposure.

1 Dedicated to Professor Dr. W. Koransky on the occasion of his 65th birthday. This study was supported by GSF, Munich, Federal Republic of Germany, and by Deutsche Forschungsgemeinschaft.

2 Present address: Institut für Tumorbiologie-Krebsforschung der Universität Wien, Borschkegasse 8a, A-1090 Wien, Austria.

3 To whom requests for reprints should be addressed.

Received 5/ 8/86. Revised 8/27/86. Accepted 9/10/86.




This article has been cited by other articles:


Home page
Cancer Res.Home page
O. Moennikes, A. Buchmann, A. Romualdi, T. Ott, J. Werringloer, K. Willecke, and M. Schwarz
Lack of Phenobarbital-mediated Promotion of Hepatocarcinogenesis in Connexin32-Null Mice
Cancer Res., September 1, 2000; 60(18): 5087 - 5091.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
B. Grasl-Kraupp, G. Luebeck, A. Wagner, A. Low-Baselli, M. de Gunst, T. Waldhor, S. Moolgavkar, and R. Schulte-Hermann
Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis)
Carcinogenesis, July 1, 2000; 21(7): 1411 - 1421.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Kroll, S. Kunz, T. Klein, and L. R. Schwarz
Effect of lindane and phenobarbital on cyclooxygenase-2 expression and prostanoid synthesis by Kupffer cells
Carcinogenesis, August 1, 1999; 20(8): 1411 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Q. Zhao, M. R. Young, B. A. Diwan, T. P. Coogan, and M. P. Waalkes
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression
PNAS, September 30, 1997; 94(20): 10907 - 10912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.